Steven L. Hoerter - 19 Nov 2024 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CCCC	Stock Option (Right to Buy)	Award	$0	+65,000		$0.000000	65,000	19 Nov 2024	Common Stock	65,000	$4.15	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	33% of the shares underlying this option shall vest and become exercisable on November 19, 2025, with the remainder vesting in eight equal quarterly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.